Oxbow Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $566K | Sell |
727
-218
| -23% | -$170K | 0.06% | 132 |
|
|
2025
Q1 | $781K | Hold |
945
| – | – | 0.08% | 121 |
|
|
2024
Q4 | $730K | Sell |
945
-147
| -13% | -$113K | 0.09% | 121 |
|
|
2024
Q3 | $967K | Buy |
1,092
+46
| +4% | +$40.8K | 0.1% | 110 |
|
|
2024
Q2 | $947K | Buy |
1,046
+25
| +2% | +$22.6K | 0.11% | 101 |
|
|
2024
Q1 | $794K | Sell |
1,021
-243
| -19% | -$189K | 0.11% | 99 |
|
|
2023
Q4 | $737K | Buy |
1,264
+1
| +0.1% | +$583 | 0.11% | 104 |
|
|
2023
Q3 | $679K | Buy |
1,263
+418
| +49% | +$225K | 0.11% | 101 |
|
|
2023
Q2 | $396K | Buy |
845
+52
| +7% | +$24.4K | 0.06% | 144 |
|
|
2023
Q1 | $272K | Hold |
793
| – | – | 0.05% | 172 |
|
|
2022
Q4 | $290K | Hold |
793
| – | – | 0.05% | 168 |
|
|
2022
Q3 | $256K | Buy |
+793
| New | +$256K | 0.04% | 206 |
|
|
2022
Q1 | – | Sell |
-975
| Closed | -$269K | – | 275 |
|
|
2021
Q4 | $269K | Hold |
975
| – | – | 0.03% | 243 |
|
|
2021
Q3 | $225K | Hold |
975
| – | – | 0.02% | 260 |
|
|
2021
Q2 | $224K | Sell |
975
-110
| -10% | -$25.3K | 0.02% | 266 |
|
|
2021
Q1 | $203K | Buy |
+1,085
| New | +$203K | 0.02% | 270 |
|
|
2020
Q2 | – | Sell |
-1,883
| Closed | -$261K | – | 282 |
|
|
2020
Q1 | $261K | Hold |
1,883
| – | – | 0.04% | 226 |
|
|
2019
Q4 | $248K | Buy |
+1,883
| New | +$248K | 0.03% | 252 |
|
|
2018
Q2 | – | Sell |
-5,326
| Closed | -$412K | – | 305 |
|
|
2018
Q1 | $412K | Sell |
5,326
-110
| -2% | -$8.51K | 0.08% | 168 |
|
|
2017
Q4 | $459K | Buy |
5,436
+113
| +2% | +$9.54K | 0.09% | 174 |
|
|
2017
Q3 | $455K | Sell |
5,323
-4,999
| -48% | -$427K | 0.09% | 163 |
|
|
2017
Q2 | $850K | Buy |
+10,322
| New | +$850K | 0.15% | 140 |
|